Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Free Cash Flow (2020 - 2025)

Agilon Health (AGL) has disclosed Free Cash Flow for 6 consecutive years, with -$23.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Free Cash Flow fell 278.7% year-over-year to -$23.5 million, compared with a TTM value of -$119.0 million through Dec 2025, down 67.55%, and an annual FY2025 reading of -$119.0 million, down 67.55% over the prior year.
  • Free Cash Flow was -$23.5 million for Q4 2025 at Agilon Health, down from -$21.3 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $13.2 million in Q4 2024 and bottomed at -$65.1 million in Q4 2023.
  • Average Free Cash Flow over 5 years is -$33.2 million, with a median of -$31.6 million recorded in 2022.
  • The sharpest move saw Free Cash Flow crashed 2076.21% in 2023, then surged 120.2% in 2024.
  • Year by year, Free Cash Flow stood at -$52.3 million in 2021, then fell by 2.2% to -$53.4 million in 2022, then dropped by 21.8% to -$65.1 million in 2023, then skyrocketed by 120.2% to $13.2 million in 2024, then tumbled by 278.7% to -$23.5 million in 2025.
  • Business Quant data shows Free Cash Flow for AGL at -$23.5 million in Q4 2025, -$21.3 million in Q3 2025, and -$38.3 million in Q2 2025.